News

A rare, genetic type of ALS seems to cluster in central Appalachia. The TRANSLATE clinical trial, led by a multidisciplinary time of clinicians and scientists, is looking for hope in an existing FDA-approved drug.

New findings from the University of Kentucky published in the Journal of Neuroscience demonstrate that there may be ways to address blood-brain barrier dysfunction in epilepsy.

Following in his father’s footsteps, Esias Bedingar came to UK in 2014 from Chad, not knowing any English at all. Since then, he has founded a nonprofit to help eradicate malaria in his home country, conducts research in neurodegenerative diseases, and will graduate with a degree in public health before attending Harvard University this fall.

A team of UK researchers have homed in on a protein, called RIT1, that may act as a master switch in the brain. A new five-year, $2.5 million grant from the National Institutes of Health will help them explore RIT1 as a possible target for treatments to counteract brain injury.

The third annual International Society of Neurogastronomy Symposium brought together experts from the worlds of food and neuroscience to explore what we eat and why.

Dr. Craig Van Horne, neurosurgeon, and Dr. George Quintero, DBS neurophysiologist at UK HealthCare's Neuroscience Institute, discuss deep brain stimulation in Sunday's Herald-Leader Your Health column.

Case Western Reserve and UK's SCoBIRC were able to show the existence of a parallel neural network that could potentially restore diaphragm function after spinal cord injury. Perhaps more amazing is that this research is credited to a group of young scientists.

Led by a multidisciplinary team of clinicians and scientists, the studies aim to develop new treatments using existing therapies that protect brain tissue after a stroke, and to learn more about the physiology of the event.

Last summer, a group from the UK Brain Restoration center, led by Dr. Craig van Horne, capped off a series of conferences held at a number of renowned Chinese university hospitals by performing the first-ever deep brain stimulation surgery for a Parkinson’s disease patient at The First Affiliated Hospital of Zhengzhou University in Henan, China.

In a prime example of the unique type of cross-collaboration that takes place at academic medical centers, Markey's stem cell lab is working together with the Kentucky Neuroscience Institute to bring an innovative stroke clinical trial to UK HealthCare.